21:42 Update on BTK inhibitors for CLL: Ibrutinib pus the new kids on the block: Are they better? HMP Education
18:36 Update on PI3K inhibitors for CLL: Idelalisib, copanlisib, duvelisib, and umbralisib HMP Education
19:42 Treatment options for the young CLL patient with deletion 17p: Do they need a different approach? HMP Education
